Rare Alpha-1-Antitrypsin Variant in Lung Disease
Author Information
Author(s): Ljujic Mila, Aleksandra Topic, Nikolic Aleksandra, Divac Aleksandra, Grujic Milan, Mitic-Milikic Marija, Radojkovic Dragica
Primary Institution: Institute of Molecular Genetics and Genetic Engineering, Belgrade
Hypothesis
Does the p.G320R variant of alpha-1-antitrypsin affect its functional activity in patients with emphysema and lung cancer?
Conclusion
The p.G320R variant is associated with reduced functional activity of alpha-1-antitrypsin protein in patients with severe pulmonary disorders.
Supporting Evidence
- The p.G320R variant was found in two patients with severe pulmonary disorders.
- Specific trypsin inhibitory activity was lower in both patients compared to healthy individuals.
- The variant was previously described in a large population study.
Takeaway
Some people have a special version of a protein that helps their lungs, but this version doesn't work as well, which can make them sick.
Methodology
The study compared specific trypsin inhibitory activity in two patients with the p.G320R variant and 19 healthy individuals.
Potential Biases
Potential bias in patient selection and the retrospective nature of some data.
Limitations
The study is limited by the small sample size and the need for further confirmation of findings.
Participant Demographics
Two male patients (one 31 years old with emphysema, one 73 years old with lung cancer) and 19 healthy individuals.
Statistical Information
P-Value
null
Confidence Interval
null
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website